Sugi Predict

Sugi Predict / Compounds / SCHEMBL2014288

SCHEMBL2014288

SCHEMBL2014288

CC(N)c1cc(F)c2cccnc2c1N1CC[C@@H](O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 6/20 0.41
▸ KDM4E B2RXH2 2/20 0.36
▸ MPI P34949 1/20 0.36
▸ ITGB2 P05107 1/20 0.35
▸ ICAM1 P05362 1/20 0.35
▸ ITGAL P20701 1/20 0.35
▸ SLC40A1 Q9NP59 2/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ ALOX12 P18054 2/20 0.35
▸ KCNMA1 Q12791 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ KRAS P01116 1/20 0.34
▸ SOS1 Q07889 1/20 0.34
▸ FFAR4 Q5NUL3 2/20 0.33
▸ CTSB P07858 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ DPP8 Q6V1X1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011474 0.87 SLC40A1 (0.42) L3MBTL1KDM4ESLC40A1HTR1ANPC1
SCHEMBL2014587 0.81 ALDH1A1 (0.42) L3MBTL1KDM4ESLC40A1NPC1ALOX12
SCHEMBL12632109 0.81 SLC40A1 (0.46) L3MBTL1KDM4ESLC40A1HTR1ANPC1
SCHEMBL2013531 0.80 PIK3CD (0.38) L3MBTL1ITGB2ICAM1ITGALKRAS
SCHEMBL2164993 0.80 HTR1A (0.44) L3MBTL1KDM4EHTR1AALDH1A1LMNA
SCHEMBL2014289 0.80 KDM4E (0.36) L3MBTL1KDM4EMPISLC40A1HTR1A
SCHEMBL2014290 0.80 KDM4E (0.36) L3MBTL1KDM4EMPISLC40A1HTR1A
SCHEMBL2163892 0.80 L3MBTL1 (0.44) L3MBTL1KDM4EMPISLC40A1HTR1A
SCHEMBL2166504 0.77 ALDH1A1 (0.40) L3MBTL1KDM4ESLC40A1NPC1ALOX12
SCHEMBL2018360 0.76 SLC40A1 (0.36) L3MBTL1KDM4EMPISLC40A1KCNMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 — — US disclosed
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 — — US disclosed
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 — — US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 — — US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 — — US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 — — US disclosed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 — — WO disclosed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS PIK3R1, PIK3R3, PIK3R2 L3MBTL1 2960/4885KDM4E 1058/4885MPI 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.